Two tests have been compared for detection of heterozygotes for phenylketonuria, one based on determination of plasma phenylalanine and tyrosine concentrations in fasting individuals and the other on kinetic evaluation of the plasma elimination curve after intravenous loading with L-phenylalanine. The plasma elimination curve was biexponential andthe kinetics were evaluated according to the two-compartment model. The constant, fi, expressing the rate of elimination from plasma at pseudo-equilibrium, the rate constant for the elimination from the central compartment, and the total body clearance were determined. Of these three, total body clearance, which on the average was reduced by 32% in the phenylketonuric heterozygotes, showed the best discriminatory ability, but was not better than the information on concentrations of phenylalanine and tyrosine in detecting heterozygotes for phenylketonuria.
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Addftlonal Keyphrases: tyrosine/phenylalanine relationships genetics diagnostic acids -inherited disorders . and age-related differences Phenylketonuria is an autosomal recessive disease characterized by a lack of phenylalanine hydroxylase (phenylalanine 4-monooxygenase, EC 1.14.16.1) activity. The enzyme is located almost exclusively in the liver (1) . Direct measurement of its activity and characterization of it in the liver would probably be the best method for detecting the heterozygous state, but liver biopsy is not now a routine method than can be performed in healthy subjects. Quite recently phenylalanine hydroxylase activity has been demonstrated in fibroblast cultures, and this activity was less in cultures from patients with phenylketonuria (2) . The possibility of detecting the heterozygous state by applying the same technique has still to be tested.
Attempts have been made to detect the heterozygous state in indirect ways, by measuring the plasma con- centrations of phenylalanine and tyrosine in the postabsorptive state (3) (4) (5) (6) or the concentrations of these amino acids after oral (7-9) or intravenous (3, 10, ii) loading with phenylalanine.
However, none of these methods has discriminated completely between phenylketonuric heterozygotes and normal homozygotes.
We have previosly reported that after intravenous injection of L-phenylalanine the plasma concentration curve declined biexponentially and that the kinetics could be evaluated according to the two-compartment model (12) . In the present study this method has been applied for investigation of heterozygotes for phenylketonuria. Furthermore,the possibility todiscriminate phenylketonuric heterozygotes from normal homozygotes by determination of the concentrations of phenylalanine and tyrosine in the plasma of fasting subjects has been tested.
Material
Reference group. This group consisted of 27 volunteers, 16 men 22 to 47 years old (mean age 28 years) and 11 women 22 to 31 years old (mean age 24 years). The weight of the men ranged between 63 and 94 kg (mean 74kg), that of the women between 42 and 62kg (mean 52 kg).None ofthe subjects had any familyhistory of phenylketonuria.
One of the men was considered to be a heterozygote for phenylketonuria according to the results in this (Figures 1, 3 , and 6) and a subsequent study that included experiments with constant infusion of L-phenylalanine (13). The results obtained for this individual were therefore excluded from the statistical calculations.
Heterozygotes for phenylketonuria.
This group consisted of 14 parents (eight men and six women) of phenylketonuric children. The age of the eight men varied between 29 and 49 years (mean 34 years) and their weight ranged between 61 and 89 kg (mean 76 kg). The age of the six women varied between 31 and 34 years and their weight ranged between 52 and 60 kg (mean 56 kg).
The diagnosis of phenylketonuria in the children was based on the following criteria: plasma phenylalanine concentration 1.2 mmol/liter and normal tyrosine concentration before dietary treatment was started; dietaryrestriction ofthedailyphenylalanineintaketo 1.5-3.0 mmol/day to reach a plasma phenylalanine concentration between 0.2 and 0.6 mmol/liter; and normal development of the children during the dietary therapy.
All subjects were apparently healthy and in good condition at the time of the study. None had any history of hepatic, renal, or endocrine disorders, and all had normal serum concentrations of creatinine, bilirubin, and activities of alkaline phosphatase, aspartate aminotransferase, and alanine aminotransferase. Four of the women in the reference group and two of the heterozygotes were taking oral contraceptives.
Methods

Intravenous
L-phenylalanine loading. The loading was done in the morning, 0800 hours, after an overnight fast. L-Phenylalanine, 300 mol/kg body weight,was given intravenously during 3-4 mm. Venous blood, collected in heparinized tubes, was drawn before the infusion and thereafter at intervals of 5 mm during the first hour and of 10 mm during the next 2 h. Analytical assays. Plasma phenylalariine and tyrosine were determined by ion exchange chromatography using a column (55 X 0.9 cm) of Aminex A-6 resin in a Beckman Model 120C amino acid analyzer. Phenylalanine and tyrosine were eluted with a sodium citrate buffer (0.2 mol/liter, pH 4.50) at a column temperature of 56 #{176}C. The plasma (1 ml) was deproteinized with sulfosalicylic acid (2 ml, 295 mmol/liter) containing D,L-f3-2-thienylalanine as internal standard. Calculations. The concentration (C) of phenylalanine in plasma minus the fasting concentration after the intravenous infusion declined biexponentially in accordance with the equation:
where A' and B' are the intercepts of the exponential terms at the end of the infusion, a (first slope)and (secondslope)arethe rateconstants, and t'represents the time after the infusion was stopped. Numerical values of the parameters were determined by least squares analysis using the DECUS No. 8-661 nonlinear regression program in conjunction with a Digital PDB 8 computer. Unweighted data were found to give the best agreement between the theoretical curves and the experimental results. The intercepts (A, B), corrected with regard to the time of the infusion, were calculated by the method of Loo and Riegelman (12) by use of the equations:
where r isthe time of the infusion.
The elimination and distribution of phenylalanine were calculated according to the following two-cornpartment model:
Assuming that the compound is eliminated from the central compartment, as indicated in the scheme, the rate constants associated with this model were calculated from the following relationships:
The volume of the central compartment (Va) was determined from V = dose/(A + B) and VP the volume of the peripheral compartment from V,, = Vdfl -V where Vd,j is the apparent volume of distribution in the 13-phase and is determined from the relationship:
The integral fCdt, which is identical to the area under the plasma concentration curve from zero to infinite time, was determined by the equation
Total body clearance was calculated by the product keiVc.
Body surface area (BSA), was estimated according to the method of Isaksson (14) .
Statistical analysis. Significance levels of differences between mean values were calculated by Student's ttest. Statistical significance has been defined as P < 0.05.
The possibility of discriminating between normal homozygotes and heterozygotes for phenylketonuria was evaluated with a nonparametric method. A discriminant function was determined visually in such a manner that a minimum number of subjects in both groups were incorrectly classified. Discriminant analysis assuming normal distribution was also used (14) .
Results
Fasting concentrations of phenylalanine and tyro-
sine. The fasting plasma phenylalanine concentration was significantly higher (P <0.001) in the heterozygotes for phenylketonuria (75 ± 10 Mmol/liter, mean ± SD) than in the controls (56 ± 9 jmol/liter), but there was no difference in the tyrosine concentration ( Figure 1) . A lower tyrosine concentration was observed in the women using oral contraceptives than in the other subjects, The fasting concentration of tyrosine in each individual was plotted vs. the fasting concentration of female subjects using oral contraceptives, 9: reference subject considered to be heterozygote forphenylketonuria. The equation forthe discriminatory line was y = 1.56x -43.5 where x is the phenylalanine and y the tyrosine concentration in MmoI/Iiter 50 tOO0 50 tOO
.4 for phenylketonuria and normal homozygotes was y = 1.56x-43.5, where x isthe phenylalanine and y the tyrosineconcentration in mol/ liter, calculated by discriminant analysis. The probability oferroneousclassification on usingthisequation was 9%. A linecould be drawn visually thatcompletely separated all phenylketonuric heterozygotes, except for one man, from the controlsubjects-i.e., one subject out of 40 was incorrectly classified.
Kinetics of phenylalanine elimination.
The timecourse of the phenylalanine concentration in plasma after the intravenous administration of L-phenylalanine, corrected for the fasting value, followed a biexponential curve in allindividuals. The average concentrations in the different groups are shown in Figure   2 and the kinetic constants of the two-compartment model in Table 1 .
The constant 13was about 20% lower in the men than in the women (Tables 1 and 2 ). No sex-related difference was observed in the elimination rate constant kei or in the total body clearance (kei' V) after correction to constant body surface area or constant body mass. The former correction gave the least interindividual variation in the clearance.
The mean value of 13was significantly lower in the heterozygotes than in the controls (Tables 1 and 2) , although the overlapping between the groups was great. The mean half-life (t112 = 0.693/13) was 1.81 ± 0.36 h (mean ± SD) and 2.25 ± 0.34 h in male controls and heterozygotes, respectively. The corresponding values for women were 1.51 ± 0.24 and 1.79 ± 0.25 h.
The elimination rate constant from the central compartment (kei) was lower (P < 0.001) in the phenylketonuric heterozygotes (0.95 ± 0.24 h) than in the controlsubjects(1.32± 0.35h) whereas the volume ofthe central compartment (Va) was similar in both groups (controls 0.24 ± 0.06 liter/kg, corresponding to 8.8 ± 2.1 liter/rn2; heterozygotes 0.24 ± 0.08 liter/kg, corresponding to 8.6 ± 2.7 liter/rn2). This resulted in a reduction of the total body clearance in the heterozygotes. The clearance value for all controls (n = 26) was 11.0 ± 1.3 liter.h1.m2
(mean ± SD) and for all heterozygotes (n = 14) 7.5 ± 1.6 liter.h.m2,
i.e., the total body clearance was decreasedby 32% inthe heterozygotes.
Total body clearance was the constantthatmost efficiently discriminated between heterozygotes for phenylketonuria and hornozygotes for the normal gene but no complete separation between the groups was attained (Figure 3 ). Four subjects (two controls and two heterozygotes) of the 40 examined were incorrectly classified when a clearanceof 9.0 liter.h.m2 was chosen as the discriminatoryvalue.This value was TIME AFTER INJECTIONS h chosen to obtain the lowest number of incorrectly classified subjects in both groups. Women who were taking oral contraceptives had a significantly (P <0.05) larger volume of the central compartment than the other women L0.32 ± 0.02 liter! kg, corresponding to 10.6 ± 1.1 liter/rn2 (n = 4), and 0.23 ± 0.07 liter/kg, corresponding to 7.7 ± 2.1 liter/rn2 (n = 7), respectively], but a lower value of the constant kei (1.05 ± 0.07 and 1.44 ± 0.12 h', respectively). Use of oral contraceptives had no apparent effect on the total body clearance of phenylalanine.
The mean values of the different constants presented in Table 1 include all women. The proportion of subjects using oral contraceptives was similar in both groups.
Tyrosine concentrations after L-phenylala nine
loading. The plasma tyrosine concentration rose significantly less after phenylalanine loading in the male heterozygotes than in the male controls (Figure 4) . The area under the curve describing the increase in the plasma tyrosine concentration was on average 48% smaller in the heterozygotes than in the control subjects alanine (300zmol/kg body weight) in reference subjects Symbols as in Fig. 1 during the first 3 h after the injection. A similar difference (56%) was seen when comparing the female groups when those using oral contraceptives were excluded. There was a less pronounced increase in the tyrosine concentration in the females of the control group using oral contraceptives than in the others ( Figure 5 ). The heterozygote group was too small to permit any conclusions in this respect.
The greatest difference in the increase in the plasma tyrosine concentration between heterozygotes and controlswas obtained earlyafterthe phenylalanine injection. Figure6 shows thatonly two subjectswere incorrectly classified if an increase in the tyrosine concentration of 17 imol/liter at 15 mm was chosen as the discriminatory level. One male heterozygoteshowed a greaterincreasethan 17 Mmol/literand one woman control who was taking oral contraceptives showed a smallerincrease. The totalarea under the increase in the plasma tyrosine concentration did not give a better discrimination between heterozygotes and normal homozygotes.
Discussion
The heterozygotes forphenylketonuria have onlyone gene coded fortheenzyme phenylalaninehydroxylase and sohave less ofthisenzyme activity than do normal homozygotes.The enzyme activity has been assessed in indirect ways. Hsia etal. (7)were the first toreport that higher plasma phenylalanine concentrations were seen in heterozygotes for phenylketonuria than in controls afteroraladministration of L-phenylalanine. Sincethen,oralloadingtests have been widelyused (9).
Rampini et al. (8) determined
the phenylalanine and tyrosine concentrations 1, 2, 3, and 4 h after theloading. By adding these concentrations, corrected by coefficients obtained by discriminant analysis, a discriminatory score was obtained. Using this score, they found a classification error about 1% if three of the 44 subjects were excluded from the original material. This result is surprisingly good, because variations in stomach emptying and gastrointestinal absorption might affect the results. Other studies have shown a considerably higher classification error (15, 16) . To avoid the potential sources of errors associated with oral administration, intravenous loading with L-phenylalanine can be done. This route of administration has previously Symbols as in Fig. 1 been used inonlya fewstudies dealing withtheproblem ofdetectingheterozygotes forphenylketonuria (3, 10, 11) . Only four to five blood samples were takeninthese previousstudiesand the possibilities of performing kinetic analysis were consequently limited. In the present study we have followed the plasma phenylalanine concentration in the time interval 5-180 mm after the intravenous administration of a single dose of L-phenylalanine, with blood sampling every 5 to 10 mm. The rateconstantsa and f3 were estimated by computer simulation using a nonlinear regression program. It was found that the first component (A.et) did not approach zero until 50 to 70 mm after the loading. Therefore, if the 13-constant is calculated from the plasma concentrations in the time interval 30-150 mm after the injection, as in the study of Bremer and Neumann (10), values were falsely high.
The determination of the rate constants in the present study was based on 24 observations. One would therefore expect a higher degree of precision, and consequently less overlapping, between heterozygotes for phenylketonuria and normal homozygotes than in previous studies (10, 11) . Instead, we obtained a more pronouncedoverlapping between the groups. Previously the rate constant for the second component of the elimination (13)has been used for detection of heterozygotesforphenylketonuria (10, 11) . Using thisconstant,which is a function of both distribution and elimination, Woolf et al. (11) found a classification error of 8% on using the 13-constant. In the study of Bremer and Neumann (10) a 13-value could be obtained visually, which incorrectly classified only two of 26 subjects studied. In our study about a third of the subjects were incorrectly classified in spite of the fact that we have considered that there appears to be a sex-related difference in this constant. A higher value was observed in women, whether control subjects or heterozygotes, but there was no sex-related difference in the total body clearance corrected to constant body surface area. In previous studies (10-12) no sex-related difference has been observed. It has to be pointed out that clearance also is equal to 13-Vd,, i.e., an increase in 13, a decrease in total distribution volume and a constant clearance, asseeninwomen ascompared withman, arecompatible results. The smallervalueofthetotal distribution volume in the women was due to a decrease in the volume of the peripheral compartment, which might reflect differences in muscle mass.
Total body clearanceand kei gave a better discrimination of heterozygotes for phenylketonuria than did the 13-constant. The total body clearance of phenylalanine,correctedto constantbody surfacearea,gave an incorrect classification of four(twoheterozygotes and two controls) of the 40 subjects examined when 9.0 liter-h1.m2 was used as the discriminatory value.
The mean totalbody clearanceofphenylalaninein the reference group of the presentstudy was significantly greater than in a previously studied group (12). This difference is most likely due to a decrease in clearancewith age as the mean age of the previous control subjects was 58 years as compared tothepresent 27 years. The phenylketonuricheterozygotes and the referencesubjectsin the presentstudy are fairly well matched as faras age isconcerned.The heterozygotes were on average six years older than the reference subjects, and thisdifference might have resultedin a slight overestimation ofthe discriminatory ability.
The mean totalbody clearanceinthe heterozygotes was 68% of that in the control group. The reduction was about the same as observed in a group of patients with cirrhosis of the liver (12). The decrease, however, seems to be due to different mechanisms.
In the cirrhotic patients the reduction of the total body clearance was due to a lower volume of the central compartment, probably due to a reduced liver pool size, whereas the elimination ratefrom the central compartment was unaffected. In the heterozygotes for phenylketonuria V was normal but the elimination rate kei was less, reflecting the decreased activity of phenylalanine hydroxylase. In several reports concerning the detection of heterozygotes forphenylketonuria, not only the change in the phenylalanine concentration but also the increase inplasma tyrosine after phenylalanine loadinghas been used as a measure of the decreasedhydroxylationof phenylalanine (9). We also found a lower tyrosine increase in the heterozygotes.
The area under the curve for increase in the plasma tyrosine concentration during the observation period was about 50% of the corresponding area in the control subjects. However, the area was nota better discriminatory variable than the plasma tyrosineincrease at 15 mm afterthe startofthe injection ( Figure 6 ). We alsonoticedthat use of oralcontraceptives resulted in a lowering of the concentration of tyrosine in the plasma of the fasting subject and a smaller increase in the tyrosine concentration after phenylalanine loading, in agreement with earlier observations (17) (18) (19) (20) . Thus, there was a risk of incorrectly classifying normal homozygotes who were taking oral contraceptives as heterozygotes for phenylketonuria. Although the elimination rate of phenylalanine after intravenous loadingwas calculated from a considerable number of observation points, the discrimination between heterozygotes for phenylketonuria and control subjects was not total. During the past year Griffin and Elsas (6) have reported good resultsby the simple method ofdeterminingthe semifasting concentrations ofphenylalanine and tyrosine. A discriminant analysis of our data in a similar way gave a probability ofincorrect classification of 9%. However, it was possible to draw a line by which only one of the 40 subjects was incorrectly classified.
We conclude that the more time-and resource-consuming method of kinetic evaluation of the curve for elimination from plasma after intravenous injection of L-phenylalanine offers no advantage for detecting heterozygotes for phenylketonuria over the method with determination of the fasting or semifasting plasma concentrations of phenylalanine and tyrosine. However, neither of these methods will permit a complete separation of heterozygotes for phenylketonuria from normal homozygotes. 
